@Hans_BMTProgram

Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.

 Toronto
uhn.ca/PrincessMargaret/Clinics/Allogeneic_Transplant
Joined March 2020
  • Tweets144
  • Following123
  • Followers198
32Media
Hans Messner Allogeneic BMT Program retweeted
Shernan Holtan MD
@sghmdOct 3
Swiss cheese ๐Ÿง€ model of why PTCy + ATG may be complementary, not redundant. @nihardesai89 emphasized lower dose ATG is key. ๐Ÿ”‘ @COSTEMCongress @Hans_BMTProgram
2
8
36
1,947
๐Ÿ“ข Now out in @BrJHaem ๐ŸŽŠ๐ŸŽ‰ Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up) onlinelibrary.wiley.com/doi/โ€ฆ
4
16
1
57
6,126
๐Ÿ“ข Published in @ASTCT_Journal ๐ŸŽ‰ Using a large dataset (@CIBMTR + @Hans_BMTProgram), we show that ATG + PTCy may alleviate the โคด๏ธGvHD risk associated with female donor-to-male recipient MUD transplants ๐Ÿ™Œ๐Ÿฝ astctjournal.org/article/S26โ€ฆ
5
14
3
80
7,736
๐ŸŽ‰ Out now in @ASTCT_Journal ๐Ÿ™Œ๐Ÿฝ We compare two conditioning regimens for second allogeneic transplant after primary graft failure! Interesting results ๐Ÿ‘‡๐Ÿฝ DM me for the PDF! sciencedirect.com/science/arโ€ฆ @Hans_BMTProgram
2
17
68
4,745
Hans Messner Allogeneic BMT Program retweeted
Ahmed AlNughmush@AhmedAlNughmush13 Jun 2025
Our work is now out in @ASTCT_Journal We looked into the association between cumulative cyclosporine exposure over the first 90 days (AUC90) post-HCT and key transplant outcomes, including graft failure and relapse. @Hans_BMTProgram astctjournal.org/article/S26โ€ฆ
1
4
10
902
Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual T-cell depletion for GVHD prophylaxis. #Hematology #BMT @AhmedAlNughmush @Hans_BMTProgram doi.org/10.1111/ejh.14438

Impact of Conditioning Intensity on Survival in Adult Patients (<โ€‰65โ€‰Years) With Acute Myeloid...

Introduction Myeloablative conditioning (MAC) for acute myeloid leukemia (AML) improves disease control by reducing relapse risk but is associated with higher non-relapse mortality (NRM). Reduced-i...

onlinelibrary.wiley.com
1
6
23
2,284
Hans Messner Allogeneic BMT Program retweeted
Arjun D. Law@Haemophage22 May 2025
Proud moment at the CTTC Conference! Hereโ€™s a roundup of phenomenal poster presentations from our team at @Hans_BMTProgram @UHN and @pmcancercentre , tackling real-world challenges in transplant medicine and GVHD. #CTTC2025 #HCT #GVHD #HemeTwitter 1/10
1
4
13
1,204
๐Ÿšจ New Study Alert! @nihardesai89 @Haemophage @IvanPasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromesโ€”a rare and challenging group of hematologic neoplasms. ๐Ÿงต๐Ÿ‘‡
2
7
1
22
5,201
Excellent thread summarising key findings of our latest publication from @pmcancercentre ๐Ÿ‘‡๐Ÿฝ DM me if you want the PDF ๐Ÿ™Œ๐Ÿฝ onlinelibrary.wiley.com/doi/โ€ฆ #MedTwitter @SergioRdzRdz @Hans_BMTProgram @Haemophage
Sergio Rodrรญguez-Rodriguez, MD, MSc. ๐Ÿ‡ฒ๐Ÿ‡ฝ@SergioRdzRdz18 May 2025
๐Ÿšจ New Study Alert! @nihardesai89 @Haemophage @IvanPasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromesโ€”a rare and challenging group of hematologic neoplasms. ๐Ÿงต๐Ÿ‘‡
3
8
1
40
4,069
The abstract titles for #ASCO25 are out ๐Ÿ™Œ๐Ÿฝ We asked 2 questions: 1. Can we โคต๏ธthe PTCy dose in MUDs? 2. What's the outcome of patients who are alive 2 yr post transplant? We'll answer those questions at the oral abstract session @ASCO #MedTwitter @Hans_BMTProgram
4
10
1
46
5,118
Hans Messner Allogeneic BMT Program retweeted
Princess Margaret Cancer Centre@pmcancercentre27 Mar 2025
Exciting news from a dear patient. Thank you for sharing your journey with us.
FergDevins
@FergDevins27 Mar 2025
After 4 weeks in @pmcancercentre @UHN and 21 days post stem cell transplant from my sister, I am discharged to home and now an out-patient. Excellent care - the recovery journey continues - sincere thanks to family and friends for your ongoing love and support
3
3
14
1,882
๐ŸŽ‰๐ŸŽ‰๐ŸŽ‰Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago! As always, I'm thankful to @Haemophage and the team at @pmcancercentre for the phenomenal mentorship ๐Ÿ™Œ๐Ÿฝ Looking forward to a great discussion and meeting some solid oncologists ๐Ÿคฃ #MedTwitter
11
6
2
107
10,038
๐ŸŽ‰๐ŸŽ‰ 200 ALLOGENEIC transplants in a year is no mean feat ๐Ÿ’ช๐Ÿฝ๐Ÿ’ช๐Ÿฝ๐Ÿ’ช๐Ÿฝ๐Ÿ’ช๐Ÿฝ๐Ÿ’ช๐Ÿฝ๐Ÿ’ช๐Ÿฝ I am proud to be a part of this amazing team ๐Ÿ’ช๐Ÿฝ P.S. We are on track for 250 this year ๐Ÿ™Œ๐Ÿฝ #MedTwitter @Haemophage @Hans_BMTProgram @PanktiMehta24 @SergioRdzRdz @NicoGagelmann
Hans Messner Allogeneic BMT Program
@Hans_BMTProgram25 Mar 2025
Huge milestone! Today our centre infused the 200th AlloBMT for this fiscal year. Thatโ€™s 200 Allogeneic Stem Cell Transplants THIS YEAR (overall weโ€™re >5k) and weโ€™re still going strong! A new record! #AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF
5
8
60
5,606
Hans Messner Allogeneic BMT Program retweeted
Arjun D. Law@Haemophage25 Mar 2025
Wow! What a phenomenal team we work with at @Hans_BMTProgram ! It truly takes a village to achieve such a monumental goal.
Hans Messner Allogeneic BMT Program
@Hans_BMTProgram25 Mar 2025
Huge milestone! Today our centre infused the 200th AlloBMT for this fiscal year. Thatโ€™s 200 Allogeneic Stem Cell Transplants and weโ€™re still going strong! A new record! #AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF
There's a new version of this post
2
12
935
I am pleased to present 3 posters and chair a session at @TheEBMT annual meeting in Florence ๐Ÿ™Œ๐Ÿฝ Can't wait to meet the mad lot we call @TheEBMT_Trainee ๐Ÿคฃ๐Ÿคฃ @Hans_BMTProgram #MedTwitter
6
4
1
56
3,914
In 2024, we performed close to 250 allogeneic transplants!! Thank you to our patients and every member of the exceptional team ๐Ÿ™๐Ÿฝ Bring on 2025 ๐Ÿ’ช๐Ÿฝ #MedTwitter @Hans_BMTProgram
8
8
87
3,564
Hans Messner Allogeneic BMT Program retweeted
Ahmed AlNughmush@AhmedAlNughmush11 Jan 2025
Does speeding up neutrophil engraftment truly make a difference? Check out our study on the impact of G-CSF post Allo-HCT journals.lww.com/transplantaโ€ฆ @AymanAbualhassa @Hans_BMTProgram

Impact of Granulocyte Colony-Stimulating Factor... : Transplantation Direct

Background.Despite decades of postโ€“allogeneic hematopoietic cell transplantation (HCT) growth factor utilization, its role remains undefined, leading...

journals.lww.com
1
7
26
1,529
It was an honour to receive the #ASH24 abstract achievement award for 3 of my abstracts๐Ÿ™Œ๐Ÿผ The alloBMT team @pmcancercentre had 2 oral presentations + 9 posters to present ๐Ÿ’ช๐Ÿผ I'm proud to work at one of the largest transplant centers in the ๐ŸŒŽ with the kindest colleagues โค๏ธ
19
10
1
202
16,491
Hans Messner Allogeneic BMT Program retweeted
YomnaEissa@YomnaEissa110 Dec 2024
Very proud to have presented this abstract in #ASH2024 showing this multicenter retrospective real-world experience with FLT3i maintenance post HCT in #FLT3ITD_positive_AML patients who received an allogeneic HCT. #world_wide_data #improved_outcomes #allelic_frequency_matters
1
4
33
1,799
Join us at our poster @ASH_hematology , presented with my partner in hematology and in life, @AhmedAlNughmush โค๏ธ #ASH24 #BMT
3
7
68
7,614
Load more